The literature concerning hepatitis B in pregnancy is reviewed and problems of management of both the acute and chronic infections are discussed.
6 (16) 17 (17) 59 (33) India (Malkani and Grewel, 1957) 8 (38) 55 (20) 81 (59) USA (Siegel et al., 1966) 4 (0) 7 (14) 22 (0) Israel (Zondek and Bromberg, 1947) 6 (0) 15 (34) Denmark (Hammerli, 1966) 3 (0) 85 (1) Australia (Bennett et al., 1967) 19 (0) 109 (0) On the other hand, a prospective study of viral infection in pregnancy (Siegel, Fuerst and Peress, 1966) has shown that there is no increase in fetal loss or congenital abnormality following hepatitis in the first half of pregnancy. The suggestion (Stoller and Collmann, 1965 ) that maternal hepatitis occurring near the time of conception is associated with an increased incidence of Down's syndrome has not (Mansell, 1955) 15 (all cases) 60 U.S.A. (Siegel et al., 1966) 65 (all cases) 8 U.S.A. (Adams and Combs, 1965) 28 (all cases) 14 been substantiated by later studies (Dietzman et al., 1972 The infants born after pregnancies complicated by jaundice seldom suffer from clinically obvious liver disease (Hsia, Taylor and Gellis, 1952; Adams and Combs, 1965) but when the offspring of the mothers who had hepatitis B are tested, many are HBFAgpositive and some have biochemical and histological evidence of liver disease (Gillespie et al., 1970; Wright et al., 1970; Turner et al., 1971; Marshall and Dudgeon, 1972) .
Hepatitis in pregnancy
The proportion of infected infants is low when the cases of maternal hepatitis occur during the first half of pregnancy, but it rises to about 50%O when the onset is within 4 weeks before or after delivery (Table 3) . The situation regarding hepatitis B carrier mothers is much less clear (Schweitzer et al., 1973) . It can be seen from Table 4 that carriers in Denmark and Greece seldom transmit to their infants while those in Taiwan often do. The reason for this difference and the mechanism of transmission are poorly understood. Many infants born to HBAg-positive mothers do not have detectable antigen in their cord blood (Smithwick and Go, 1970; Skinh0j et al., 1972) , but some of these HB5Ag-negative infants subsequently develop antigenaemia (Table 3) . Conversely infants with HBsAg-positive cord blood may rapidly become negative. Although they have clearly been exposed, some of these infants produce no subsequent evidence of infection.
The age at which infected infants become HBAgpositive varies, but it is usually before the sixth week of life (Merrill, Dubois and Kohler, 1972; Schweitzer et al., 1973; Hitchins, Gostling and O'Driscoll, 1974) . This suggests that transmission occurs during the last few weeks of gestation if an average incubation period of 90 days is expected. However, the chance of avoiding contact with maternal blood during delivery is so remote that it is possible that all infants are exposed at that time and that some failure of the mother's infection governs the outcome in the infant.
The titre of the maternal antigen correlated well with the likelihood of transmission in Taiwan but not in England (Cossart and Cohen, 1976) . In any event the correlation could well be indirect since the titres found in acute hepatitis patients are usually higher than those in asymptomatic carriers.
The subtype of the antigen is also unlikely to explain the difference between individuals since the prevailing subtype is ad amongst the 'non-transmitting' carriers in Denmark and England but ay in Greece, while the 'transmitting' carriers in the Far East have the ad subtype. Not enough is known about the minor determinants in this context, but they may reflect important strain differences amongst hepatitis B viruses.
So far, the most important factor recognizable in determining transmission from mother to infant is the activity of the mother's liver disease, but this is difficult to assess during pregnancy because of the physiological alterations in liver function. Many 'healthy' carriers have chronic hepatitis which is only revealed by specific investigation and in at least one larger series from the U.S.A. (Schweitzer, Edwards and Brezina, 1975) where 'carriers' were reported to have transmitted hepatitis to their infants it is clear that the authors' definition included mothers with chronic hepatitis following an acute attack of 'hippie hepatitis'. It is still too early to know whether the e antigen will be a reliable indicator of the risk of transmission and in particular serve to identify those exceptional carriers who are at risk of producing severely affected infants in subsequent pregnancies (Kohler et al., 1974) .
Very little is known about the outlook for infants who acquire hepatitis B in the first few months of life. The first reports showed that severe (Wright et al., 1970; Marshall and Dudgeon 1972; McCarthy, 1973) and even fatal (Fawaz et al., 1975; Kohler et al., 1974) liver disease could occur but as more cases have been studied it has become obvious that long term, asymptomatic carriage is the more usual result. This is to be expected in view of the immaturity of the immune response at this age, but it is not yet known how many of the infants are able to clear the antigen as they get older (Dahlquist and Nordenfelt, 1974) .
Those who remain persistent carriers may suffer from chronic liver disease in later life. Familial No action (? no risk transmission to infant).
Look for non-infective causes.
clustering of hepatitis B infections is well recognized in some communities (Ohbayashi, Okochi and Majumi, 1972; Mazzur, Blumberg and Frielaender, 1974) and circumstantial evidence suggests that a carrier mother is often the source of infection. However, transplacental transmission does not occur often enough to account for the number of adult carriers in Western Europe or North America. It may well be the major factor in other countries such as Taiwan while in yet other areas children who are chronic carriers frequently present with non-hepatic manifestations of 'immune complex disease' such as glomerulonephritis (Brozosko et al., 1974) . The factors responsible for these differences in response are unknown.
The management of individual patients presents problems which are summarized in Table 5 . The infant born to a mother with acute hepatitis B near term is clearly at risk of infection and the administration of specific hepatitis B immunoglobulin to these infants should be considered. Half the adult dose has been used (Fawaz et al., 1975; Kohler et al., 1974; Cossart and Cohen, 1976) but its efficacy in these circumstances is unproved. It is often convenient to separate mother and infant until the mother's hepatitis subsides, but post-natal exposure by personal contact or because the milk contains HBAg (Boxall, 1975 ) is likely to be trivial compared with that during delivery.
The mother with acute hepatitis is better isolated since it will seldom be known whether she has hepatitis A or B when she is admitted. Carriers in England seldom transmit to their infants so a policy of non-intervention seems best for the group. Routine screening of pregnant women for HBsAg cannot be justified as a preventive measure, and separation of mother and infant is misguided when it is unlikely that the mother will become HB.Agnegative within a foreseeable time. There is no evidence that breast feeding is a significant factor in transmitting hepatitis B to the infants of carriers and its prohibition is probably unnecessary.
The actual delivery of HBsAg-positive patients may present hazards to the staff. The main risk is from accidental inoculation with a blood-stained needle and the general hospital policy should include arrangements for the routine reporting of all such incidents so that specific immunoglobulin can be offered whenever it is warranted.
Apart from this, the main problem is the laundry and it is certainly advisable to send all the patient's bed linen to the hospital 'soiled wash'. It is convenient for the nursing staff if a single room is available so that the infant can remain 'rooming in' with the mother. After they go home the room should be cleaned with a dilute chlorine-based disinfectant but more rigorous measures are unnecessary.
In this context it is important to remember that every maternity ward will deal with far more unrecognized carriers than those identified by a chance HBAg test. If the general routine is satisfactory there will be no need to provide specific facilities for known carriers.
